Current portfolio companies of SightLine Healthcare Funds III, IV and Vintage.

Anulex, Inc.
Status: Private
Funds: Fund III, IV, Vintage Fund
Minnetonka, MN

http://www.anulex.com

Medical devices for repairing the anulus, the outer wall of the spinal disc.  (Spinout from ProtoStar incubator)

Broncus Technologies, Inc.
Status: Private
Funds: Fund III, Vintage Fund
Mountain View, CA

www.broncus.com

Medical devices for the treatment of lung diseases.

CVRx, Inc.
Status: Private
Funds: Fund III, IV, Vintage Fund
Maple Grove, MN

www.cvrx.com

Medical devices for the cardiovascular market. (Spin out from Protostar incubator)

LipoScience, Inc.
Status: Private
Funds: Fund III, Vintage Fund
Raleigh, NC

http://www.liposcience.com
In Vitro diagnostic company committed to advancing patient care in cardiovascular, metabolic and other diseases using an innovative and proprietary technology platform based on nuclear magnetic resonance, or NMR.

Verax Biomedical, Inc.

Status: Private

Fund: Fund IV

Worcester, MA

www.veraxbiomedical.com

Leading developer of rapid tests for the detection of bacterial contaminants in blood components, tissues for transplantation and cellular therapies.

Selected prior portfolio companies of Funds I, II, III, IV and Vintage.

Acorn Cardiovascular, Inc.
Status: Acquired
Funds: Fund III, Vintage Fund
St. Paul, MN

Medical devices for the treatment of congestive heart failure.  Sold in December 2010.

Alsius Corporation
Status: Public, "ALUS", Acquired
Fund: Fund II
Irvine, CA

Proprietary technology targeting severe traumatic brain injury, ischemic stroke and cardiac arrest.  Acquired by ZOLL in July 2009.

Altiva Corporation
Status: Acquired
Fund: Fund III
Charlotte, NC

Medical devices for the spine.  Acquired by Exatech in January 2008.

AngioGuard, Inc.
Status: Acquired
Fund: Fund II
Minneapolis, MN

Proprietary medical devices to reduce the risk of embolization in interventional procedures. Acquired by Johnson & Johnson in July 1999.

Asthmatx, Inc.
Status: Acquired
Fund: Fund III
Mountain View, CA

Developing an interventional medical device for the bronchoscopic treatment of patients with severe asthma.  Acquired by Boston Scientific in November 2010.

Atritech, Inc.
Status: Acquired
Funds: Fund III, IV, Vintage Fund
Plymouth, MN

Medical devices for the prevention of atrial fibrillation related stroke.  Acquired by Boston Scientific in March 2011.

Axya Medical, Inc.
Status: Acquired
Fund: Fund II
Beverly, MA

Proprietary technology for the welding of surgical sutures and polymers for minimally invasive surgery and tissue approximation. Sold in June 2006.

CardioGenesis Corporation
Status: Public, Exited, Acquired
Fund: Fund I
Irvine, CA

Medical devices for the treatment of coronary artery disease. Acquired by Eclipse Surgical Technologies in March 1999.

Conceptus, Inc
Status: Public "CPTS", Exited
Fund: Fund I
San Carlos, CA

Less invasive technology for use in reproductive medicine.

Endocardial Solutions, Inc.
Status: Public "ECSI", Exited, Acquired
Fund: Fund I
St Paul, MN

Minimally invasive technology for the diagnosis of abnormal heart rhythms. Acquired by St. Jude Medical in January 2005.

Endovascular Technologies, Inc.
Status: Public, Exited, Acquired
Fund: Fund I
Menlo Park, CA

Technology that enables endovascular repair of diseased or damaged vascular structures. Acquired by Guidant in December 1997.

Exogen, Inc.
Status: Public, Acquired
Fund: Fund I
Piscataway, NJ

Medical technologies focused on the biophysical treatment of musculoskeletal injury and disease. Acquired by Smith and Nephew in September 1999.

Fox Hollow Technologies, Inc.
Status: Public, Exited, Acquired                     
Fund: Fund II                                             
Menlo Park, CA


Medical devices primarily for the treatment of peripheral artery disease.  Acquired by EV3 in May 2005.

InnerDyne, Inc.
Status: Public, Exited, Acquired
Fund: Fund I
Sunnyvale, CA

Minimally invasive surgical access products. Acquired by Tyco in October 2000.

Innovasive Devices, Inc.
Status: Public, Exited, Acquired
Fund: Fund I
Marlborough, MA

Proprietary tissue repair systems which facilitate the repair of soft tissue injuries. Acquired by Johnson & Johnson in November 1999.

InSound Medical, Inc.
Status: Acquired
Funds: Fund III, Vintage Fund
Newark, CA

Minimally invasive implantable hearing device.  Acquired by Sonova in January 2010.

Insulet Corporation
Status: Public "PODD", Exited
Fund: Fund IV
Beverly, MA

Disposable insulin pumps for treatment of diabetes.

Micro Interventional Systems, Inc.
Status: Acquired
Fund: Fund I
Sunnyvale, CA

Medical technologies for the interventional neuroradiology and interventional radiology markets. Acquired by Medtronic in November 1995.

Solarant Medical
Status: Acquired
Fund: Fund II
Pleasanton,CA

Innovative technology to cure female stress urinary incontinence.

Acquired by American Medical Systems in May 2006.

Suros Surgical Systems, Inc.
Status: Acquired
Fund: Fund IV
Indianapolis, IN

Medical device manufacturer of a minimally-invasive tissue excision and biopsy device. Acquired by Hologic, Inc. in July 2006.

Urologix, Inc.
Status: Public, Exited
Fund: Fund I
Minneapolis, MN

Minimally-invasive medical devices for the treatment of urological disorders.

To learn more about our Medical Technologies focus, click here.

Back To Portfolio Companies